Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons F. Sarno, Dr

Publicaties

DNA methylation as a driver of lung fibroblast senescence in COPD

UVI5008: the first reversible, non-covalent Bruton’s tyrosine kinase epi-inhibitor for B-cell malignancies

Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach

The Promise of Epigenetic Editing for Treating Brain Disorders

Cancer Therapy Resistance: Choosing Kinase Inhibitors

Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing

Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing

Functional Validation of the Putative Oncogenic Activity of PLAU

In-silico guided chemical exploration of KDM4A fragments hits

Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.